top of page
Supported projects
HEMERION Therapeutics
Healthtech company developing a novel intraoperative photodynamic therapy combining a photosensitising drug and a laser device to selectively destroy residual brain tumour cells.
PSCC's entrance
June 2026
Localization
FR - Hauts de France
Modality
MD/Drug Combinaison
Development status
Biotech - Phase 1/2, Medtech - Development
Award(s)
bottom of page